Sunday, October 25, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· December 24, 2025

Micron surge is bullish for these other stocks, says Bank of America

View original at finance.yahoo.com
Micron surge is bullish for these other stocks, says Bank of America I started investing in the 1990s and joined Wall Street on the sell side in 1997…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Semicap equipment will see 10%/14% YoY growth in CY26/27E towards $131bn/$150bn driven by fab upgrades to support high-bandwidth memory, higher layer count NAND, leading-edge logic and advanced packaging

    80% confidence
  • Reasoning models answering challenging queries could require over 100 times more compute compared to single-shot inference

    80% confidence
  • KLA is a best-in-breed stock and is the one stock in his coverage that he has never downgraded from a 'buy' rating

    80% confidence
  • Process control will gain 100 bps of share to 13% of WFE in 2026

    80% confidence
  • Training is significantly and increasingly compute-intensive, and compute needs are accelerating rapidly, particularly as more models move into production

    80% confidence
  • Etch/dep (AMAT/LRCX) could expand to 42% of share, up 3% since 2023, with NAND and HBM contributing to gains for all three companies

    80% confidence
  • FCF margins at AMAT, LRCX, and KLAC could reach 20% to 30% through 2028

    80% confidence
  • To address tight supply-demand conditions extending beyond 2026, capital spending in fiscal 2026 will be approximately $20 billion weighted to the second half of the fiscal year

    80% confidence
  • Semicaps will outperform in CY26 as upstream beneficiaries of capacity expansions and tech upgrades to support multi-year AI infra demand, with upside in C2H'26 and CY27 as visibility into capex plans and fab ramp timelines improves

    80% confidence
  • Semicap trading at a premium to historical multiples, but there is potential for continued EPS upgrades given consensus models' bottom-up sales growth (6-8% annual) below our top-down WFE (10%+) forecast

    80% confidence
  • Micron's sales and profit will jump to $18.7 billion and $8.42 per share in the upcoming quarter

    80% confidence
  • 2026 will feature another ~30% growth towards the first $1tn for semiconductor sales, supported by nearly double-digit YoY wafer fab equipment (WFE) sales growth

    80% confidence
  • This WFE upcycle is more powerful and durable than previous ones, suggesting continued semicap outperformance in CY26

    80% confidence
  • An evolving supercycle could be a strong tailwind for semiconductor equipment and manufacturing stocks, including those tied to memory capital expenditures

    80% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Enterprise Software Races to Govern and Consolidate Around Agentic AI
Enterprise software vendors are repositioning around autonomous AI agents. Salesforce is acquiring Braze, ServiceNow is launching agent governance tools (AI Passport, Super Intelligence Control Tower), SAP is pushing its 'Autonomous Enterprise', and Zeta is launching AthenaOS and its own inference model. Palantir is embedding itself in banking, aviation and sovereign AI infrastructure through partnerships with Customers Bank, Surf Air, Ondas and Armada. Governance, data sovereignty and enforced policy are emerging as preconditions for regulated sectors like finance. Investors such as Norwest see room to disrupt ERP and finance software, and they caution that AI should not be trusted with financial calculations. Consolidation and shareholder disputes (Salesforce/Braze, Tiny/Oso Cloud, ZenaTech/Boardwalktech) show the market reshaping.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,500 source documents archived
Query this data → isubstrate.com
Micron surge is bullish for these other stocks, says Bank of America — Source | Via News | Via News